Amifostine in Treating Patients With Myelodysplastic Syndrome
Completed
National Cancer Institute (NCI)
Phase 2
1997-06-05
RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
myelodysplastic syndrome.
Amifostine in Treating Patients With Myelodysplastic Syndrome
Completed
M.D. Anderson Cancer Center
Phase 2
1997-06-05
RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
myelodysplastic syndrome.
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
Completed
University of California, San Francisco
Phase 2
1997-05-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving the drugs in different
combinations may kill more tumor cells.
PURPOSE: Randomized phase II double-blinded trial to study the effectiveness of paclitaxel
and carboplatin given with either amifostine or placebo in patients with metastatic stage III
or stage IV ovarian cancer or metastatic stage III or stage IV non-small cell lung cancer.
Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
Unknown status
Providence Hospital
Phase 2
1997-08-01
RATIONALE: Amifostine may be effective in helping blood counts return to normal in treating
patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
advanced myelodysplastic syndrome.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
